Sio Gene Therapies OverviewSio Gene Therapies Operating Income
Operating Income for SIOX.
Quarterly Operating Income
$-4620000.00
↓ 81.85% YoY
As of Dec 31, 2022
Annual Operating Income (TTM)
$-29576000.00
↓ 58.21% YoY
Trailing 12 months ending Dec 31, 2022